BACKGROUND: We previously demonstrated that a putative anti-tumor gene, peroxisomal membrane protein 4, 24 kDa (PMP24 or PXMP4), is silenced via DNA methylation of a CpG island in its 5' flanking region (5'-CGI) in prostate cancer (PCa) cells. METHODS: To identify demethylation hypersensitive site(s) in PMP24 5'-CGI, PC-3 cells with methylated 5'-CGI were treated with a low-dose of 5-aza-2'-deoxycytidine (5-aza-dC) just sufficient to reactivate gene expression, referred as the limited demethylation approach. Gel shift assays and promoter analyzes were performed to demonstrate the role of the hypersensitive site in PMP24 gene regulation. Transfection of a methylated oligonucleotide corresponding to the hypersensitive site was conducted to determine the effect of site-specific methylation on the gene expression. Bisulfite sequencing analysis was performed to reveal the methylation status of PMP24 promoter in cultured cells and microdissected samples. In situ hybridization was applied to determine expression positivity of PMP24 mRNA. RESULTS: A 5-aza-dC hypersensitive site encompasses two CpG dinucleotides in intron 1 was identified. Methylation of the first, but not the second, CpG dinucleotide of this site disrupted DNA-protein interactions and suppressed the gene expression. Using archival specimens, we found the first CpG dinucleotide of the hypersensitive site is hypermethylated with a loss of PMP24 mRNA expression in microdissected PCa cells when compared to normal prostatic epithelial cells. CONCLUSIONS: These findings support a critical role for a single intronic CpG dinucleotide in PMP24 gene regulation through DNA methylation. The data suggest that methylation-mediated silencing of PMP24 is a molecular event associated with prostate carcinogenesis.
BACKGROUND: We previously demonstrated that a putative anti-tumor gene, peroxisomal membrane protein 4, 24 kDa (PMP24 or PXMP4), is silenced via DNA methylation of a CpG island in its 5' flanking region (5'-CGI) in prostate cancer (PCa) cells. METHODS: To identify demethylation hypersensitive site(s) in PMP24 5'-CGI, PC-3 cells with methylated 5'-CGI were treated with a low-dose of 5-aza-2'-deoxycytidine (5-aza-dC) just sufficient to reactivate gene expression, referred as the limited demethylation approach. Gel shift assays and promoter analyzes were performed to demonstrate the role of the hypersensitive site in PMP24 gene regulation. Transfection of a methylated oligonucleotide corresponding to the hypersensitive site was conducted to determine the effect of site-specific methylation on the gene expression. Bisulfite sequencing analysis was performed to reveal the methylation status of PMP24 promoter in cultured cells and microdissected samples. In situ hybridization was applied to determine expression positivity of PMP24 mRNA. RESULTS: A 5-aza-dChypersensitive site encompasses two CpG dinucleotides in intron 1 was identified. Methylation of the first, but not the second, CpG dinucleotide of this site disrupted DNA-protein interactions and suppressed the gene expression. Using archival specimens, we found the first CpG dinucleotide of the hypersensitive site is hypermethylated with a loss of PMP24 mRNA expression in microdissected PCa cells when compared to normal prostatic epithelial cells. CONCLUSIONS: These findings support a critical role for a single intronic CpG dinucleotide in PMP24 gene regulation through DNA methylation. The data suggest that methylation-mediated silencing of PMP24 is a molecular event associated with prostate carcinogenesis.
Authors: C Nguyen; G Liang; T T Nguyen; D Tsao-Wei; S Groshen; M Lübbert; J H Zhou; W F Benedict; P A Jones Journal: J Natl Cancer Inst Date: 2001-10-03 Impact factor: 13.506
Authors: James A Mobley; Irwin Leav; Patrick Zielie; Chad Wotkowitz; James Evans; Ying-Wai Lam; Byung Suk L'Esperance; Zhong Jiang; Shuk-Mei Ho Journal: Cancer Epidemiol Biomarkers Prev Date: 2003-08 Impact factor: 4.254
Authors: Shuanfang Li; Roberta Hansman; Retha Newbold; Barbara Davis; John A McLachlan; J Carl Barrett Journal: Mol Carcinog Date: 2003-10 Impact factor: 4.784
Authors: George S Watts; Bernard W Futscher; Nicholas Holtan; Koen Degeest; Frederick E Domann; Stephen L Rose Journal: BMC Med Genomics Date: 2008-09-30 Impact factor: 3.063
Authors: David A Nielsen; Sara Hamon; Vadim Yuferov; Colin Jackson; Ann Ho; Jurg Ott; Mary Jeanne Kreek Journal: Hum Genet Date: 2010-03-18 Impact factor: 4.132
Authors: Veronica Ceccarelli; Serena Racanicchi; Maria Paola Martelli; Giuseppe Nocentini; Katia Fettucciari; Carlo Riccardi; Pierfrancesco Marconi; Paolo Di Nardo; Francesco Grignani; Luciano Binaglia; Alba Vecchini Journal: J Biol Chem Date: 2011-06-09 Impact factor: 5.157
Authors: George S Krasnov; Alexey A Dmitriev; Nataliya V Melnikova; Andrew R Zaretsky; Tatiana V Nasedkina; Alexander S Zasedatelev; Vera N Senchenko; Anna V Kudryavtseva Journal: Nucleic Acids Res Date: 2016-01-14 Impact factor: 16.971